Search

everythinglearnresearchcommunity

for

Search:↓

2011 dermatology discussions highlighted stem cell hair treatments, new lichen planopilaris therapies, skin side effects from cancer drugs, emerging allergens, and the link between food allergies and skin issues.

Low-level light therapy is FDA-approved for male pattern hair loss, increases hair count and strength, and is considered safe for use.

Up to half of adult women may experience hair loss, and doctors should use medical history, exams, and tests to find the cause and treat it.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

The document emphasizes early detection and treatment of men's skin conditions and recommends protective measures and appropriate treatments for different age groups.

The document concludes that accurate diagnosis and treatment are crucial in dermatology, and it presents various findings on skin conditions and treatments.

The conclusion suggests that the zinc lozenge study is valid despite imperfect blinding, as many participants could not correctly identify their lozenge type.

The document concludes that more research is needed on the hepatitis B vaccine's side effects and the effectiveness of certain treatments for specific diseases.

Taking high doses of fluconazole for a long time can cause reversible hair loss.

Long-term high-dose fluconazole can cause reversible hair loss.

International medical graduates scored higher than U.S. graduates on a medical exam.

In 1995, international medical graduates did better than U.S. graduates on a medical exam.

Skin symptoms are important for diagnosing infections in children.

Cyclosporin doesn't stop hair loss.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

The conclusion is that obesity should be managed with a slow, balanced approach to diet and exercise, with medication and surgery as additional options, and education and access to care are important.

Human skin acts like a hormone-producing organ, making and managing various hormones important for skin and hair health.

Antigen presenting cells around hair follicles are crucial in SLE-related hair loss.

Nanostructured delivery systems could potentially improve hair loss treatment by targeting drugs to hair follicles, reducing side effects and dosage, but the best size, charge, and materials for these systems need further investigation.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Breast cancer hormone therapy can cause hair loss, which can be treated with daily applications of specific topical solutions like minoxidil and hydrocortisone butyrate.

Regulating cell death in hair follicles can help prevent hair loss and promote hair growth.

Prunus mira kernels contain components that can promote hair growth in mice.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

Ethosomes could improve how well skin treatments work, but more research is needed on their safety and stability.

COVID-19 infection may cause hair loss.

A man with itchy skin lesions and weight loss was diagnosed with a rare skin condition linked to a pancreatic tumor.

Colorectal cancer development involves both genetic changes and epigenetic alterations like DNA methylation and microRNA changes.

PROTO1 and PROTO2 protect against hearing damage.